Nath Bio-Genes (India) Ltd - 537291 - Financial Results For The Period Ended 30.09.2020
Financial Results for the period ended 30.09.202007-11-2020
07-11-2020
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2020.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2020 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended 30th September 2020.29-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Change in Management
Revised Disclosure for Appointment of Mrs. Ashu Jain as Independent Director (additional).28-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Mrs. Ashu Jain as Independent Director (additional).27-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Submission Of Compliance Certificate For The Half Year Ended 30Th September, 2020 - Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015 (''Listing Regulations'')
Submission of Compliance Certificate for the half year ended 30th September, 2020 - Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (''Listing Regulations'')17-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate Under Regulation 7(3) Of SEBI LODR
Compliance Certificate under Regulation 7(3) SEBI LODR14-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 201812-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended September 30, 2020
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here12-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- DHIRAJ RATHIDesignation :- Company Secretary and Compliance Officer07-10-2020
Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading Window30-09-2020